Perioperative administration of single, high-dose of ATG-Fresenius-S as an induction immunosuppressive therapy in cadaveric renal transplantation: preliminary results

Transplant Proc. 2001 Sep;33(6):2952-4. doi: 10.1016/s0041-1345(01)02268-0.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase III
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Antilymphocyte Serum / therapeutic use*
  • Cadaver
  • Female
  • Follow-Up Studies
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / physiology
  • Male
  • Middle Aged
  • Safety
  • Time Factors
  • Tissue Donors

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents